- Global Pharma News & Resources

Tissue Transplantation Products and Services Market Application 2020 – Industry Trends, Global Analysis, Tissue transplantation Technology, Business Growth & Demand, Top 5 Leading Players, Sectors & Services and Forecast by 2026

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.


Chronic diseases are catastrophic to human organs and can lead to permanent damage of vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines. Under such severe conditions, transplants remain the only resolution for healthy life. Tissue transplantation and services market has seen an increased demand especially from high income countries. High prevalence of diseases such as diabetes, cancer, cardiovascular diseases, renal diseases and Alzheimer’s disease have post a threat of irreversible tissue damage to a large population globally. According to an article published in the Journal of Diabetes Care, in 2010, prevalence of diabetes related end stage renal disease escalated from 17,727 in 1990 to 48,215 in 2006 in the U.S. Large percentage of cancer patients need to undergo bone marrow transplant. Bone marrow and peripheral blood stem cell transplantation procedures are essential in restoration of stem cells that have been destroyed due to high doses of chemotherapy and radiation treatment. According to World Health Organization, globally, over 14 million new cases and 8.2 million cancer related deaths were recorded in 2012. Thus, a large target population base exists for companies in the global tissue transplantation products and services market.

Get FREE Sample PDF Including COVID-19 Impact Analysis:

Global Tissue Transplantation Market Segment

  • Based on the Tissue Type
    • Cornea
    • Heart Valve
    • Skin Grafts
    • Vascular Grafts
    • Bone Marrow
    • Bone Grafts

Tissue transplantation products mainly comprised of processed stem cells, which involve multiplication and differentiation according to a patient’s requirements. Government standards and guidelines have been set for storage and processing of stem cells for therapeutic purposes. Some of the government as well as private service providers include NHS Blood and Transplant, Tissue Services, U.K., LifeCell Corporation, Mid-America Transplant Services, Australian Red Cross Blood Service. These institutes provide storage and processing services to transplant patients. Bone marrow storage banks have been of prime importance, as they help in finding appropriate match for transplant.

Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Autologous stem cell transplant has become convenient mainly due to advent of induced pluripotent stem cells (iPSC). Scientists are trying to develop organs from human induced pluripotent stem cells (iPSCs). An article published in Nature in 2013, reports the generation of a functional human organ from pluripotent stem cells. This technique surpasses the risk of immunosuppression and graft-vs-host disease associated with bone marrow transplant. Although expensive, the chances of success are higher in case of iPSC transplant procedures. Currently, the market for tissue transplant products and services is mainly driven by various advancements in iPSC methods.

As the technology is in its nascent stage of development, immense scope exists for players to enter the market. However, changing regulatory policies, and practice of un-approved tissue transplantation, especially in South-East Asia Pacific countries has hindered growth of tissue transplant products and services market. In response to increasing demand, government funding is also expected to increase for more research in tissue transplant across the globe. As companies receive approvals for application of tissue transplant, market for service providers is expected to increase drastically. As more safety standards are established, the global tissue transplantation products and services market would enter in its growth phase. The U.S., Japan, and major European countries are preferred targets for market entry.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @

Key Players: Abbott, Biomet, CryoLife, Inc., Arthrex, Exactech, Inc., Celera, Folio Biosciences, Köhler Chemie, Bristol-Myers, LifeCell Corporation, Centacor and Novartis.

Key Developments

Key players in the market are focused on various business strategies such as partnership and collaboration, in order to gain competitive edge in the market. For instance, in May 2019, researchers from AMALNA Consulting and RMIT University, collaborated with Tithon Biotech Inc. to predict the characteristic frequencies related to parathyroid hormone activities, particularly differentiation of stem cells into osteoblasts. The research findings can aid in development of improved techniques for differentiation of stem cells in tissue transplantation and repair.

Similarly, in December 2018, the study ‘Pathological Process of Prompt Connection between Host and Donor Tissue Vasculature Causing Rapid Perfusion of the Engineered Donor Tissue after Transplantation’, published in the journal MDPI International Journal of Molecular Sciences, found that donor myocardial cell sheets including endothelial cell networks and potent pericytes could connect to host vasculature causing rapid donor tissue perfusion within 24 hours after transplantation.

In July 2018, researchers from St. Marianna University School of Medicine, Japan attempted to isolate adipose-derived stem/stromal cells from cryopreserved adipose tissue with the aim of developing a banking system and found that transplantation of adipose-derived stem/stromal cells derived from cryopreserved tissue significantly aided in restoring hindlimb movement function in injured model rats.

Other Exclusive Reports:

Regenerative Therapies Market, By Tissue Type (Allograft, Xenograft, Alloplast), By Application (Soft Tissue Repair, Cardiovascular, Dental, Orthopedic, CNS disease treatment, Others), By End User (Hospitals, Ambulatory Surgical Centers, Educational Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share Outlook, and Opportunity Analysis, 2019 – 2027

Tissue Plasminogen Activator Market, By Dosage (2mg, 50mg, and 100mg), By Route of Administration (Intravenous and Regional Intra-Arterial), By Application (Blood Clots, Pulmonary Embolism, Myocardial Infarction, and Stroke), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis, 2018 – 2026

Tissue Banking Market, by Product (Media and Consumables, and Equipment), by Tissue (Bone, Brain & Spinal Cord, Cornea, Heart Valves, Skin, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 19-Nov-2020